Overall rank by patents
#36,062
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61G (TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES).
The verdict
Karma holds 7 US patents across 5 technology areas, rank #36,062 of 50,000 tracked assignees.
Karma Medical Products Co., Ltd. has been granted 7 US utility patents between 2015 and 2024, placing Karma Medical Products Co., Ltd. at rank #36,062 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 6.4 claims per patent with primary concentration in A61G (TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES). As a Foreign Corporation, Karma Medical Products Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Karma sits between Kangstem Biotech Co., Ltd. (7 patents, rank #36,058) and KBIO Holdings Limited (7 patents, rank #36,066) - the closest US assignees by grant volume. The composite Innovation Score of 21.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 3 in the 2015–2019 window, a +33% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Karma Medical Products Co., Ltd.'s 6.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Karma Medical Products Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
KANGSTEM BIOTECH CO., LTD.
7 patents
KANNUU PTY LTD.
7 patents
KANSAI CHEMICAL ENGINEERING CO., LTD.
7 patents
KARL MAYER TEXTILMASCHINENFABRIK GMBH
7 patents
KATUN CORPORATION
7 patents
KAWAKAMI SANGYO CO., LTD.
7 patents
KBC GROEP NV
7 patents
KBIO HOLDINGS LIMITED
7 patents
KARMA MEDICAL PRODUCTS CO., LTD.
7 patents
What this shows Karma holds 7 patents at rank #36,062, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #36,062 in granted patent volume.
Other assignees with the most granted patents in Karma's primary technology class.
Karma's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
21 Top 92% higher than 8% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 28.6% |
| 2016 | 1 | 14.3% |
| 2020 | 3 | 42.9% |
| 2024 | 1 | 14.3% |
Top 5 of 5 technology areas
Overall rank by patents
#36,062
Across all tracked assignees
21.2 out of 100
How to use this portfolio
Karma's 7 grants land it in the top 92% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.